These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 12807999)
1. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. Shackleford DM; Faassen WA; Houwing N; Lass H; Edwards GA; Porter CJ; Charman WN J Pharmacol Exp Ther; 2003 Sep; 306(3):925-33. PubMed ID: 12807999 [TBL] [Abstract][Full Text] [Related]
2. Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs. Lespine A; Chanoit G; Bousquet-Melou A; Lallemand E; Bassissi FM; Alvinerie M; Toutain PL Eur J Pharm Sci; 2006 Jan; 27(1):37-43. PubMed ID: 16198549 [TBL] [Abstract][Full Text] [Related]
3. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU. White KL; Nguyen G; Charman WN; Edwards GA; Faassen WA; Porter CJ J Pharmacol Exp Ther; 2009 Nov; 331(2):700-9. PubMed ID: 19696095 [TBL] [Abstract][Full Text] [Related]
4. The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps. Schnabel PG; Bagchus W; Lass H; Thomsen T; Geurts TB Clin Endocrinol (Oxf); 2007 Apr; 66(4):579-85. PubMed ID: 17371478 [TBL] [Abstract][Full Text] [Related]
5. Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate. Zgair A; Dawood Y; Ibrahem SM; Lee JB; Feng W; Fischer PM; Gershkovich P Molecules; 2021 Jan; 26(1):. PubMed ID: 33466340 [TBL] [Abstract][Full Text] [Related]
6. Solid Self-Emulsifying Drug Delivery System (Solid SEDDS) for Testosterone Undecanoate: In Vitro and In Vivo Evaluation. Liang X; Hua Y; Liu Q; Li Z; Yu F; Gao J; Zhang H; Zheng A Curr Drug Deliv; 2021; 18(5):620-633. PubMed ID: 32887542 [TBL] [Abstract][Full Text] [Related]
7. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems. Wu H; Zhou A; Lu C; Wang L Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic study in women of three different doses of a new formulation of oral testosterone undecanoate, Andriol Testocaps. Houwing NS; Maris F; Schnabel PG; Bagchus WM Pharmacotherapy; 2003 Oct; 23(10):1257-65. PubMed ID: 14594344 [TBL] [Abstract][Full Text] [Related]
9. Does stereoselective lymphatic absorption contribute to the enantioselective pharmacokinetics of halofantrine In Vivo? Shackleford DM; Porter CJ; Charman WN Biopharm Drug Dispos; 2003 May; 24(4):153-7. PubMed ID: 12698498 [TBL] [Abstract][Full Text] [Related]
10. [Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats]. Jia Y; Cue YG; Wang XD; Wang XH; Tong JS; Ma DZ; Cai RF; Di FS Zhonghua Nan Ke Xue; 2005 Jan; 11(1):38-41. PubMed ID: 15704680 [TBL] [Abstract][Full Text] [Related]
11. Solidification of Nanostructured Lipid Carriers Loaded Testosterone Undecanoate: In Vivo and In Vitro Study. Hua Y; Li W; Cheng Z; Zhao Z; Yin X; Li Y; Sun J; Gao J; Zhang H; Zheng A Drug Res (Stuttg); 2018 Aug; 68(8):457-464. PubMed ID: 29589341 [TBL] [Abstract][Full Text] [Related]
12. The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen. Coert A; Geelen J; de Visser J; van der Vies J Acta Endocrinol (Copenh); 1975 Aug; 79(4):789-800. PubMed ID: 1173974 [TBL] [Abstract][Full Text] [Related]
13. Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheep. McLennan DN; Porter CJ; Edwards GA; Martin SW; Heatherington AC; Charman SA J Pharmacol Exp Ther; 2005 Apr; 313(1):345-51. PubMed ID: 15579493 [TBL] [Abstract][Full Text] [Related]
14. Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Horst HJ; Höltje WJ; Dennis M; Coert A; Geelen J; Voigt KD Klin Wochenschr; 1976 Sep; 54(18):875-9. PubMed ID: 966635 [TBL] [Abstract][Full Text] [Related]
15. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. Caliph SM; Charman WN; Porter CJ J Pharm Sci; 2000 Aug; 89(8):1073-84. PubMed ID: 10906731 [TBL] [Abstract][Full Text] [Related]
16. The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623). Trevaskis NL; McEvoy CL; McIntosh MP; Edwards GA; Shanker RM; Charman WN; Porter CJ Pharm Res; 2010 May; 27(5):878-93. PubMed ID: 20221896 [TBL] [Abstract][Full Text] [Related]
17. Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency. Park NC; Yan BQ; Chung JM; Lee KM Aging Male; 2003 Jun; 6(2):86-93. PubMed ID: 12898792 [TBL] [Abstract][Full Text] [Related]
18. Important effect of food on the bioavailability of oral testosterone undecanoate. Bagchus WM; Hust R; Maris F; Schnabel PG; Houwing NS Pharmacotherapy; 2003 Mar; 23(3):319-25. PubMed ID: 12627930 [TBL] [Abstract][Full Text] [Related]
19. An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat. Trevaskis NL; Porter CJ; Charman WN Drug Metab Dispos; 2006 May; 34(5):729-33. PubMed ID: 16467133 [TBL] [Abstract][Full Text] [Related]
20. Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status. Haren M; Chapman I; Coates P; Morley J; Wittert G Age Ageing; 2005 Mar; 34(2):125-30. PubMed ID: 15596419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]